Targeting the Warburg effect in breast cancer with chiral derivatives of flavonoids
Science Letters · 16.04.2026
DOI: 10.48797/sl.2026.461 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Letters, erschienen am 16.04.2026. Verfasst von Manuel Bidarra und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Triple-negative breast cancer (TNBC) is the breast cancer subtype with the worst prognosis due to a lack of expression of human epidermal growth factor receptor 2 or hormone receptors [1]. Furthermore, TNBC cells exhibit metabolic reprogramming, prioritizing glycolysis even when oxygen is available. This metabolic shift, known as the Warburg effect, not only enhances tumor resistance to cytotoxic agents but also fuels its invasive behavior [2]. Flavonoids are examples of bioactive compounds with demonstrated antitumor activity, and their conjugation with amino acids has been reported to increase their cytotoxic effects [3]. Our studies further demonstrate that chiral derivatives of flavonoids (CDFs) showed promising anticancer potential.
Objective
This study aims to investigate the cytotoxicity and mechanistic profile of a specific enantiomeric pair of CDFs (TriCe- LTrp and TriCe-DTrp) on two TNBC cell lines (MDA-MB-231 and Hs578T) and a non-tumor control cell line (MCF-10A).
Methods
Cell viability was assessed to determine the selectivity index of the selected CDFs. The metabolic profile, evaluated by quantifying glucose and lactate, and the induction of apoptosis, measured by Annexin V flow cytometry, were analyzed following treatment. Additionally, cell cycle distribution was characterized using propidium iodide flow cytometry to further evaluate the effects of the compounds on the tumor cell lines.
Results
Both TriCe-LTrp and TriCe-DTrp exhibited low GI50 values in MDA-MB-231 and Hs578T cell lines. TriCe-LTrp demonstrated high selectivity on both tumor lines, with high selectivity indices, whereas TriCe-DTrp showed no selectivity, highlighting the critical role of chirality. Regarding metabolism, TriCe-DTrp significantly decreased lactate production in both lines and glucose consumption in Hs578T cells. Conversely, TriCe-LTrp reduced glucose consumption in both cell lines, but only significantly in Hs578T cells, though its impact on lactate was not significant. Flow cytometry analysis using Annexin V and propidium iodide revealed that TriCe-LTrp significantly induced apoptosis in MDA-MB-231 cells, while similar trends for TriCe-LTrp in Hs578T and for TriCe-DTrp in both lines did not reach significance.
Conclusions
These findings identify TriCe-LTrp as a highly selective and potent lead compound for triple-negative breast cancer therapy due to its dual ability to modulate tumor metabolism and induce apoptosis.
Schlagwörter
Zitieren
APA
Bidarra, M., Barbosa, F., Pinto, C., Bousbaa, H., Cidade, H. M., Tiritan, M. E., Cunha, A., & Queirós, O. (2026). Targeting the Warburg effect in breast cancer with chiral derivatives of flavonoids. Science Letters. https://doi.org/10.48797/sl.2026.461
Vancouver
Bidarra M, Barbosa F, Pinto C, Bousbaa H, Cidade HM, Tiritan ME, et al. Targeting the Warburg effect in breast cancer with chiral derivatives of flavonoids. Science Letters. 2026. doi:10.48797/sl.2026.461
BibTeX
@article{Bidarra2026,
author = {Bidarra, Manuel and Barbosa, Flávia and Pinto, Cláudia and Bousbaa, Hassan and Cidade, Honorina M. and Tiritan, Maria Elizabeth and Cunha, Andrea and Queirós, Odília},
title = {Targeting the Warburg effect in breast cancer with chiral derivatives of flavonoids},
journal = {Science Letters},
year = {2026},
doi = {10.48797/sl.2026.461}
}
EUVIMED